Fecal microbiota transplantation capsules

BIOLOGICAL4 trials

Sponsors

Montefiore Medical Center, Alice Højer Christensen, Massachusetts General Hospital, Changhai Hospital

Conditions

Advanced Gastric CancerAuto-Brewery SyndromeGut Fermentation SyndromeIrritable Bowel SyndromeUlcerative Colitis

Early Phase 1

Fecal Microbiota Transplant for Autobrewery Syndrome

Active, not recruitingNCT06083142

Massachusetts General HospitalAuto-Brewery Syndrome, Gut Fermentation Syndrome

Start: 2025-02-14End: 2030-08-31Target: 8Updated: 2026-04-17

Phase 1

The Effect of Fecal Microbiota Transplantation in Ulcerative Colitis

CompletedNCT03711006

Alice Højer ChristensenUlcerative Colitis

Start: 2017-02-01End: 2017-11-30Updated: 2018-10-18

Phase 2

Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome

CompletedNCT02328547

Montefiore Medical CenterIrritable Bowel Syndrome

Start: 2015-05-31End: 2018-03-31Updated: 2019-07-02

Unknown Phase

Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer

RecruitingNCT06346093

Changhai HospitalAdvanced Gastric Cancer

Start: 2024-04-02End: 2030-06-30Target: 124Updated: 2025-06-10

Related Papers

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.

2019-07-17106 citations